Thaum Lub Yim Hli 25-27, 2026, CPHI Kaus Lim Kauslim 2026 (Lub Ntiaj Teb Pharmaceutical Ingredients Kauslim Exhibition) tau qhib loj heev ntawm COEX Convention thiab Exhibition Center hauv Seoul, Kaus Lim Qab Teb. Raws li ib qho ntawm cov khoom lag luam loj tshaj plaws thiab muaj txiaj ntsig zoo tshaj plaws nyob rau hauv Asia, thaj chaw nthuav tawm mus txog 13,000 square metres, sib sau ntau dua 370 tus neeg tuaj koom los ntawm ntau dua 80 lub teb chaws thiab cheeb tsam thoob ntiaj teb, thiab 10,200 tus neeg tuaj xyuas. Cov qauv kev nthuav qhia ntau yam tsis yog tsuas yog nqa cov khoom pov thawj thiab cov thev naus laus zis tshiab, tab sis kuj tsim kom muaj kev sib txuas lus dav dav thiab kev koom tes platform rau cov neeg tuaj koom thiab cov qhua. Ntawm qhov kev tshwm sim kev lag luam no, Suzhou Biosynergy Pharmaceutical Co., Ltd. kuj tau ua qhov zoo tshaj plaws, tuaj koom qhov kev teem caij txhua xyoo hauv kev lag luam tshuaj raw khoom nrog cov neeg koom tes thoob ntiaj teb.
Suzhou Biosynergy Pharmaceutical tau koom nrog kev nthuav qhia tshuaj rau ntau xyoo. Raws li tag nrho - txuas tus khub los ntawm kev tshawb pom molecular, txheej txheem kev txhim kho rau kev tsim khoom lag luam, nws tsom mus rau R&D thiab tsim cov tshuaj biomedicine, siab -kawg kws tshuaj intermediates thiab APIs, npog monoclonal antibodies, ADCs, me me molecule toxins, thiab mRNA Tshuaj tiv thaiv nucleoside raw cov ntaub ntawv thiab cov khoom loj ntawm cov khoom tseem ceeb - peptides/GLP-1, antibodies, ADCs thiab biosimilars. Peb tau cog lus los ua haujlwm nrog cov neeg siv khoom thoob ntiaj teb nrog cov khoom lag luam zoo thiab cov kev pabcuam tshaj lij los koom ua ke txhawb kev txhim kho kev lag luam biopharmaceutical.
Ntawm qhov kev nthuav qhia no, Suzhou Biosynergy Pharmaceutical tau raug pom zoo los ntawm KDMF ua thawj - kab mob khaub thuas. Oseltamivir tau dhau los ua qhov tseem ceeb ntawm kev mloog hauv qhov kev nthuav qhia no. Ntau cov neeg siv khoom nthuav tawm tau muaj nyob rau hauv - sib sib zog nqus tob nyob ib puag ncig nws cov cim qhia thiab kev cia siab rau daim ntawv thov. Ntxiv nrog rau oseltamivir, peb cov khoom tseem ceeb ADC me me molecule co toxins thiab peptides kuj tau nyiam heev, tshwj xeeb tshaj yog nws yog GLP-1 thiab lwm yam receptor agonist sawv cev los ntawm semaglutide, tilpotide, thiab retalglutide. Kev sib tham ntawm qhov kev thov rau cov tshuaj generic thiab APIs, nrog rau kev lag luam tshuaj, thiab lwm yam yog khaus. Nrog rau lub platform thoob ntiaj teb no, Biosynergy Pharmaceutical Biotech tau tsim kev sib cuag nrog cov neeg siv khoom hauv ntau lub khw xws li Kaus Lim Qab Teb, Europe, Tebchaws Asmeskas, thiab Sab Hnub Tuaj Asia kom nthuav dav thoob ntiaj teb kev koom tes.
Peb -hnub kev nthuav qhia tau ua tiav tiav. Los ntawm qhov kev nthuav qhia no, Suzhou Biosynergy Pharmaceutical tsis tsuas yog ua kom cov neeg siv khoom nkag siab thiab paub txog lub tuam txhab cov khoom, tab sis kuj tsim kev sib raug zoo nrog kev sib raug zoo nrog cov neeg koom tes los ntawm ntau lub teb chaws, tso lub hauv paus ruaj khov rau tom ntej hauv - kev koom tes tob. Peb tseem yuav txhawb nqa kev lag luam lub tswv yim ntawm "kev ncaj ncees, kev tshaj lij, kev tsim kho tshiab", ua haujlwm nrog peb cov neeg koom tes los txhim kho ua ke, thiab txuas ntxiv sau ib tshooj tshiab ntawm kev sib nrig sib pab thiab yeej- yeej!